PROMETRIKA Announces New Leadership Team Member

UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care

The Yozma Group Korea, Atain Specialty Insurance Company and the Weizmann Institute of Science participated in the round.

Jon Hopkins New Senior Vice President-Chief Development Officer of Legion Healthcare Partners

Over the past 23 years, Jon has held various positions at Varian Medical Systems including Director of Sales, Americas West & Latin America, Varian Proton Solutions and prior Director of Worldwide Sales, Varian Particle Therapy.

Sinan Batman Appointed CTO of TeraRecon

Batman brings rich industry experience to TeraRecon, including Chief Engineer at Carestream/Kodak Health Group, where he defined the vision for image-centric workflow information systems.

PROMETRIKA, LLC has announced that Heather Paden, MS, has joined their Leadership Team as Head of Clinical Operations. Ms. Paden brings to this position over 20 years of diverse experience in clinical research, including operational and scientific leadership roles, clinical trial management and monitoring, publication planning, product lifecycle management, and clinical training and education.

The company reports that Heather will lead Clinical Operations in day-to-day trial management activities and in the development of systems and procedures to further enhance PROMETRIKA’s delivery of best-in-class clinical research.

PROMETRIKA’s President and CEO Miganush Stepanians said, “Heather’s experience and approach is a natural fit for our company.” Regarding leadership Stepanians added, “As a leader in clinical research and operations, she has always excelled at translating business and scientific objectives into pragmatic working plans throughout the execution of clinical studies, ensuring high levels of quality and efficiency. This approach is one of the many reasons I am excited to have her join our leadership team.”

Ms. Paden’s leadership roles have included Head of Clinical Development Operations at ContraFect Corp., Senior Consultant at Halloran Consulting, and Director of Clinical Development Medical Affairs at Boehringer Ingelheim Pharmaceuticals. Her work has covered orphan indications in oncology, cardiovascular disease, and genetic disorders.

“I am eager to bring my years of experience in cross-disciplinary management of large and small trials to this growing full-service CRO”, said Ms. Paden. “I am equally as enthusiastic to be part of an organization that sees the value in a collaborative team approach to clinical trials, and look forward to working with the entire team.”

Paden received her Masters of Science in Respiratory Care, Clinical Trial Design, and Project Management from Northeastern University, and her Bachelor of Science (Respiratory Care) and Bachelor of Arts (Human Biology) degrees from the University of Kansas.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles